Condition
Neurally Mediated Syncope
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06356207Recruiting
Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study
NCT05751330Not ApplicableUnknownPrimary
Italian Cardioneuroablation Study for Neurocardiogenic Syncope Patients
NCT02388087Not ApplicableUnknownPrimary
The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study
Showing all 3 trials